Lumen’s unique drug development and manufacturing platform offers the potential to transform the biologics industry through increased speed, mass-market scale, and exponentially lower costs than current approaches.

Brian started his career practicing law out of Harvard Law School as a corporate lawyer representing biotech companies for 10 years, his entry into the industry.

In this Medium account, my cofounder (Jim) and I share broader thoughts on the drug development process and the biopharmaceuticals industry in a voice that is more accessible than our formal publications.

Stay Connected:



Connect with Brian Finrow
Brian Finrow

Jim and I started Lumen Bioscience in 2017 to develop and commercialize ultra-low-cost biologics.